News
-
-
-
COMMUNIQUÉ DE PRESSE
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
CHMP recommends EU approval for Sanofi's Cenrifki (tolebrutinib) to treat secondary progressive multiple sclerosis without relapses. Positive opinion based on HERCULES phase 3 study -
COMMUNIQUÉ DE PRESSE
Communiqué de presse : Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées
Sanofi's Cenrifki (tolebrutinib) recommended for EU approval by CHMP for secondary progressive multiple sclerosis without relapses, based on positive results from HERCULES phase 3 study -
COMMUNIQUÉ DE PRESSE
Ringmetall SE increases revenues in the 2025 financial year thanks to successful acquisitions
Ringmetall SE increases revenues by 7.3% in 2025 financial year due to successful acquisitions. EBITDA slightly down. Liner division sees 41.8% growth. 2026 forecast: EUR 185-205 million revenue -
COMMUNIQUÉ DE PRESSE
Inside Information / Other news releases
Séché Environnement announces approval of all resolutions at the Combined General Meeting held on April 24, 2026, with key highlights of operations and fiscal results. Next event: Consolidated Results as of June 30, 2025 on September 9, 2025 -
COMMUNIQUÉ DE PRESSE
Informations privilégiées / Autres communiqués
L'Assemblée générale mixte du 24 avril 2026 de Séché Environnement approuve toutes les résolutions, dont le dividende inchangé et le renouvellement des mandats. Résultats et compte-rendu disponibles le 28 avril 2026 sur www.groupe-seche.com -
-
-
